Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Samhällsbyggnadsbolaget i Norden AB (publ) (”SBB”) in connection with its newly established subsidiary SBB Residential Property AB entering into a capital raise agreement with an investment fund managed by Morgan Stanley Real Estate Inve
Mandate

Vinge has advised Samhällsbyggnadsbolaget i Norden AB (publ) (”SBB”) in connection with its newly established subsidiary SBB Residential Property AB entering into a capital raise agreement with an investment fund managed by Morgan Stanley Real Estate Investing (“MSREI”).

July 25, 2023 Capital Markets and Public M&A Employment and Benefits Banking and Finance IT, Telecommunications and Outsourcing Data protection and processing of personal data

Pursuant to the agreement, SBB Residential Property AB will issue SEK 2.36 billion of preference shares to MSREI. The preference shares will be issued by an entity to be named SBB Residential Property AB forming a new group within SBB.

Following the transaction, MSREI will hold a minority stake in SBB Residential Property AB. The transaction is subject to customary closing conditions but not competition clearance. Closing will occur as soon as all closing conditions have been fulfilled, which is expected to occur around mid August 2023.

Vinge’s team consisted mainly of Mikael Ståhl, Jesper Schönbeck, Rikard Lindahl, Niclas Winnberg, Helena Göransson, Ulrich Ziche, Maria Dahlin Kolvik, Kristoffer Larsson, Frida Ställborn, Joel Magnusson, Kamyar Najmi, Nour Makie, Ida Redander and Filip Magnusson.

Related

Vinge advises Investor on its co-investment in the SEK 55 billion public offer for Fortnox led by EQT X

 Vinge advises Investor AB (publ) (“Investor”) on its co-investment in the public offer for Fortnox AB (publ) (“Fortnox”) led by EQT X together with First Kraft AB (owned by Olof Hallrup), acting through Omega II AB (“Omega II”). Fortnox offers vital software infrastructure to small and medium-sized companies in Sweden with a track record of profitable growth.
July 22, 2025

Vinge advises Cantargia in connection with the sale of immunology program CAN10

 Vinge advises Cantargia AB (publ) in connection with the sale of its early-clinical stage IL1RAP immunology program CAN10 to the Japanese healthcare company Otsuka Pharmaceutical.
July 21, 2025

Vinge has assisted PulPac in connection with it obtaining a €20 million financing from the European Investment Bank

 Vinge has assisted Gothenburg-based sustainable packaging technology company PulPac in connection with it obtaining a €20 million (around 220 million Swedish kronor) financing from the European Investment Bank (EIB).
July 18, 2025